Bessemer Group Inc United Therapeutics Corp Transaction History

Bessemer Group Inc

  • $55.8 Billion
  • Q1 2025

A detailed history of Bessemer Group Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Bessemer Group Inc holds 2,866 shares of UTHR stock, worth $832,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,866
Previous 8,913 67.84%
Holding current value
$832,257
Previous $3.15 Million 71.89%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025
SELL
$304.42 - $380.78 $1.84 Million - $2.3 Million
-6,047 Reduced 67.84%
2,866 $884,000
Q4 2024

Feb 13, 2025
SELL
$348.66 - $410.0 $16,735 - $19,680
-48 Reduced 0.54%
8,913 $3.15 Million
Q3 2024

Nov 12, 2024
BUY
$311.04 - $363.55 $2.77 Million - $3.24 Million
8,909 Added 17132.69%
8,961 $3.21 Million
Q1 2024

May 13, 2024
SELL
$210.76 - $249.51 $882,873 - $1.05 Million
-4,189 Reduced 98.77%
52 $12,000
Q4 2023

Feb 09, 2024
SELL
$214.88 - $256.94 $91,753 - $109,713
-427 Reduced 9.15%
4,241 $932,000
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $5,930 - $6,950
28 Added 0.6%
4,668 $1.05 Million
Q2 2023

Aug 10, 2023
BUY
$205.19 - $232.99 $7,797 - $8,853
38 Added 0.83%
4,640 $1.03 Million
Q1 2023

May 10, 2023
SELL
$212.99 - $276.17 $425 - $552
-2 Reduced 0.04%
4,602 $1.03 Million
Q4 2022

Feb 13, 2023
BUY
$205.95 - $280.43 $6,178 - $8,412
30 Added 0.66%
4,604 $1.28 Million
Q3 2022

Nov 09, 2022
BUY
$203.3 - $244.17 $31,104 - $37,358
153 Added 3.46%
4,574 $958,000
Q1 2022

May 12, 2022
BUY
$166.16 - $213.96 $224,482 - $289,059
1,351 Added 44.01%
4,421 $793,000
Q4 2021

Jan 27, 2022
BUY
$184.32 - $216.08 $206,438 - $242,009
1,120 Added 57.44%
3,070 $663,000
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $8,993 - $10,744
50 Added 2.63%
1,950 $360,000
Q1 2021

May 13, 2021
SELL
$153.94 - $174.85 $8,004 - $9,092
-52 Reduced 2.66%
1,900 $317,000
Q4 2020

Feb 09, 2021
BUY
$101.87 - $151.79 $5,297 - $7,893
52 Added 2.74%
1,952 $296,000
Q3 2020

Nov 12, 2020
SELL
$99.9 - $121.13 $686,912 - $832,889
-6,876 Reduced 78.35%
1,900 $192,000
Q2 2020

Aug 05, 2020
BUY
$92.74 - $125.82 $813,886 - $1.1 Million
8,776 New
8,776 $1.06 Million
Q1 2019

May 13, 2019
SELL
$107.15 - $126.84 $11,679 - $13,825
-109 Closed
0 $0
Q3 2018

Nov 06, 2018
BUY
$113.81 - $129.46 $12,405 - $14,111
109 New
109 $14,000
Q4 2017

Jan 30, 2018
SELL
$118.58 - $151.28 $16,008 - $20,422
-135 Closed
0 $0
Q3 2017

Nov 03, 2017
BUY
$114.6 - $136.81 $15,471 - $18,469
135
135 $16,000

Others Institutions Holding UTHR

# of Institutions
733
Shares Held
43.6M
Call Options Held
124K
Put Options Held
122K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $13.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email